Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01624727 · ClinicalTrials.gov registry record · NA
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
A NA study of Metabolic Syndrome and Coronary Heart Disease, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 338
- Enrollment target
- 2
- Study locations
NCT01624727 is a NA study of Metabolic Syndrome and Coronary Heart Disease that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 338 participants, below the 1,202-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01624727, a NA study of Metabolic Syndrome and Coronary Heart Disease, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 338 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to target inflammation to reduce progression of noncalcified plaque in the coronary arteries using omega-3 fatty acid supplementation compared to standard of care.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Omega 3 acid ethyl esters
Study Locations (2)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- South Shore Medical Group - Milton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2009-06 |
| Est. Completion | 2015-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01624727
The ClinicalTrials.gov registry entry for NCT01624727 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,202-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (72% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Omega 3 acid ethyl esters is the first listed.
NCT01624727 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01624727 about?
NCT01624727 is a clinical study titled "Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids". The purpose of the study is to target inflammation to reduce progression of noncalcified plaque in the coronary arteries using omega-3 fatty acid supplementation compared to standard of care.
What is the current status of trial NCT01624727?
This trial is currently completed. It is a NA study. The enrollment target is 338 participants. The study started on 2009-06. Estimated completion is 2015-01-15.
What conditions does trial NCT01624727 study?
This clinical trial studies the following conditions: Metabolic Syndrome, Coronary Heart Disease.
What interventions are being tested in trial NCT01624727?
The interventions under investigation include: Omega 3 acid ethyl esters (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01624727?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01624727 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Animal and Plant Proteins and Glucose Metabolism
RECRUITING · NA
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.